journal article·2023-05

Application of Calcium Alginate Hydrogels in Semisolid Extrusion 3D Printed for the Production of Easy‐to‐Swallow Tablets

Giovanni Falcone, Sonja Kuth, Aldo R. Boccaccini, Rita P. Aquino, Tiziana Esposito, Paola Russo

Advanced Engineering Materials· Volume 25· Issue 9
Publisher page

Abstract

To maximize the potential of 3D printing, several technological issues must be overcome, especially in the case of semisolid extrusion (SSE), where the 3D model is built up through the well‐defined extrusion of polymeric ink. Focusing on natural polymers, their physicochemical properties should be deeply investigated to evaluate 3D printability. This study aims to produce tablets easy to swallow, exploiting as 3D printing ink a crosslinked alginate hydrogel added of sorbitol, speculating that the plasticising action of sorbitol should allow to improve tablets’ swallowability. Three different amounts of 70% sorbitol solution (5%, 15%, 25% v/v) are evaluated to identify the best composition in terms of both printing and technological properties. The data obtained from the chemical, rheological, and mechanical evaluation of each ink are related to the printing performance, to reach the best manufacturing reproducibility. Linear regression fitting study (r 2 = 0.9982) confirms the predictable relationship between residual mass of final platforms and sorbitol amount loaded. To characterize the final products, all dried batches are subjected to technological evaluation highlighting differences in the matrix softability as well as in the swelling/erosion properties after the interaction with biological fluids.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Innovative Microfluidic and Catalytic Techniques Innovation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy University of Salerno 84084 Fisciano SA Italy

Program in Drug Discovery and Development University of Salerno 84084 Fisciano SA Italy

Institute of Biomaterials University of Erlangen-Nuremberg 91058 Erlangen Germany

References (74)

Show source-provided references
1. Use C.F.M.P.F.H European Medicines Agency (EMA) Guideline on Development Production Characterization and Specifications for Monoclonal Antibodies and Related Products 2009; EMEA/CHMP/BWP/157653: 2007.
2. Administration U. F. D. · 2013
3. 10.1016/j.futures.2018.03.00210.1016/j.futures.2018.03.002 ↗
4. 10.3390/jpm1108074510.3390/jpm11080745 ↗
5. 10.1146/annurev-genom-082410-10144610.1146/annurev-genom-082410-101446 ↗
6. Goetz L. H. · Fertilitysterility · 2018 · 109 · 952
7. 10.1172/JCI14634310.1172/JCI146343 ↗
8. 10.3892/br.2017.92210.3892/br.2017.922 ↗
9. 10.1016/j.addr.2021.11385710.1016/j.addr.2021.113857 ↗
10. 10.2174/156720104348000910.2174/1567201043480009 ↗
11. 10.1016/j.techfore.2009.09.00510.1016/j.techfore.2009.09.005 ↗
12. Soni A. · Int. J. Pharm. Compd · 2018 · 22 · 108
13. 10.1016/j.addr.2020.07.01210.1016/j.addr.2020.07.012 ↗
14. 10.1146/annurev-pharmtox-052120-09351710.1146/annurev-pharmtox-052120-093517 ↗
15. 10.1016/j.tips.2018.02.00610.1016/j.tips.2018.02.006 ↗
16. 10.3390/molecules2709278410.3390/molecules27092784 ↗
17. A.Savini G.Savini inProc. of the 2015 ICOHTEC/IEEE international history of high-technologies and their socio-cultural contexts conference (HISTELCON) IEEE Piscataway NJ2015 pp.1–8.10.1109/HISTELCON.2015.7307314 ↗
18. 10.1557/s43578-021-00407-y10.1557/s43578-021-00407-y ↗
19. 10.1016/j.actbio.2019.08.04410.1016/j.actbio.2019.08.044 ↗
20. 10.1016/j.ijpharm.2018.01.03610.1016/j.ijpharm.2018.01.036 ↗
21. 10.1016/j.actbio.2017.05.02510.1016/j.actbio.2017.05.025 ↗
22. 10.1080/17425247.2019.166031810.1080/17425247.2019.1660318 ↗
23. 10.1016/j.prosdent.2020.02.02110.1016/j.prosdent.2020.02.021 ↗
24. 10.1016/j.carbpol.2021.11779110.1016/j.carbpol.2021.117791 ↗
25. 10.1021/acs.molpharmaceut.5b0051010.1021/acs.molpharmaceut.5b00510 ↗
26. 10.1080/17425247.2017.137169810.1080/17425247.2017.1371698 ↗
27. 10.1016/j.ijpharm.2018.01.02410.1016/j.ijpharm.2018.01.024 ↗
28. 10.1016/j.ijpharm.2015.07.06710.1016/j.ijpharm.2015.07.067 ↗
29. Liang K. · Sci. Adv. · 2018 · 4
30. 10.1016/j.ijpharm.2019.02.02510.1016/j.ijpharm.2019.02.025 ↗
31. 10.1016/j.ijpharm.2021.12138610.1016/j.ijpharm.2021.121386 ↗
32. 10.1016/j.ijpharm.2019.11849710.1016/j.ijpharm.2019.118497 ↗
33. 10.1007/s00228-012-1417-010.1007/s00228-012-1417-0 ↗
34. Seoane-Viaño I. · Adv. Drug Delivery Rev. · 2021 · 332 · 367
35. 10.1016/j.ijpharm.2010.11.00110.1016/j.ijpharm.2010.11.001 ↗
36. 10.1517/17425247.4.1.3710.1517/17425247.4.1.37 ↗
37. 10.1016/j.ijpharm.2016.03.01710.1016/j.ijpharm.2016.03.017 ↗
38. 10.1208/s12248-013-9511-510.1208/s12248-013-9511-5 ↗
39. Ruiz F. · PLoS One · 2019 · 14
40. 10.1016/j.ejpb.2011.02.00510.1016/j.ejpb.2011.02.005 ↗
41. 10.1208/s12249-015-0313-110.1208/s12249-015-0313-1 ↗
42. 10.1016/j.xphs.2017.07.00910.1016/j.xphs.2017.07.009 ↗
43. 10.1517/17425247.2011.55321710.1517/17425247.2011.553217 ↗
44. 10.1016/j.jpeds.2013.07.01410.1016/j.jpeds.2013.07.014 ↗
45. 10.1016/j.ijpharm.2015.01.02310.1016/j.ijpharm.2015.01.023 ↗
46. 10.3390/polym1304057810.3390/polym13040578 ↗
47. 10.1016/j.colsurfa.2008.05.04710.1016/j.colsurfa.2008.05.047 ↗
48. 10.1016/j.polymertesting.2018.02.01610.1016/j.polymertesting.2018.02.016 ↗
49. 10.1016/j.msec.2017.05.14410.1016/j.msec.2017.05.144 ↗
50. 10.1016/j.mser.2020.10054310.1016/j.mser.2020.100543 ↗
51. 10.3390/ijms2303128010.3390/ijms23031280 ↗
52. 10.1088/1758-5090/ab98e510.1088/1758-5090/ab98e5 ↗
53. 10.1016/j.carbpol.2021.11874610.1016/j.carbpol.2021.118746 ↗
54. Sheskey P. J. · 2017
55. 10.3109/1083745090341965310.3109/10837450903419653 ↗
56. 10.1557/s43578-021-00276-510.1557/s43578-021-00276-5 ↗
57. 10.1007/BF0146084610.1007/BF01460846 ↗
58. 10.1533/9781845696429.1.1310.1533/9781845696429.1.13 ↗
59. Bingham E. C. · 1917
60. Mezger T. · Eur. Coat. · 2020
61. 10.1088/1758-5090/aacdc710.1088/1758-5090/aacdc7 ↗
62. 10.1002/mats.20210003210.1002/mats.202100032 ↗
63. 10.1088/1758-5090/aa8dd810.1088/1758-5090/aa8dd8 ↗
64. 10.1007/s10570-018-2142-310.1007/s10570-018-2142-3 ↗
65. 10.1080/0363904080258779910.1080/03639040802587799 ↗
66. 10.3109/1083745980902863310.3109/10837459809028633 ↗
67. 10.1080/10837450.2017.133264210.1080/10837450.2017.1332642 ↗
68. 10.1016/0378-5173(84)90023-110.1016/0378-5173(84)90023-1 ↗
69. 10.1016/j.colsurfb.2018.02.05010.1016/j.colsurfb.2018.02.050 ↗
70. 10.1002/jps.260071090410.1002/jps.2600710904 ↗
71. 10.1016/j.reactfunctpolym.2004.01.00210.1016/j.reactfunctpolym.2004.01.002 ↗
72. 10.1016/j.ejpb.2009.07.00810.1016/j.ejpb.2009.07.008 ↗
73. 10.1016/j.carbpol.2015.12.01010.1016/j.carbpol.2015.12.010 ↗
74. 10.5006/1.328776410.5006/1.3287764 ↗